Novavax Says COVID Vaccine Approved by US FDA in Restricted Cases; Shares Rise Pre-Bell

MT Newswires Live

May 19, 2025

Novavax's (NVAX) COVID-19 vaccine has been approved for use by the US Food and Drug Administration but limited to only those over 65 years old and to those over 12 years old with underlying medical conditions, news outlets reported Saturday, citing company officials.

Reuters cited Novavax's Chief Corporate Affairs and Advocacy Officer Silvia Taylor as saying the approval for the drug, sold under the name Nuvaxovid, came late Friday night.

Novavax did not immediately reply to MT Newswires' request for comment.

Novavax Chief Executive John Jacobs described the approval as a "significant milestone" in a statement cited by Reuters.

Shares of the US biotech firm were up more than 16% in recent premarket activity Monday.

Price: 7.86, Change: +1.13, Percent Change: +16.79

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2536077235"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2536077235\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2536077235?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-19 17:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2536077235","market":"sg","top_or_hot":-1,"title":"Novavax Says COVID Vaccine Approved by US FDA in Restricted Cases; Shares Rise Pre-Bell","media":"MT Newswires Live","content":"<html><body><p> Novavax's (NVAX) COVID-19 vaccine has been approved for use by the US Food and Drug Administration but limited to only those over 65 years old and to those over 12 years old with underlying medical conditions, news outlets reported Saturday, citing company officials.</p><p>Reuters cited Novavax's Chief Corporate Affairs and Advocacy Officer Silvia Taylor as saying the approval for the drug, sold under the name Nuvaxovid, came late Friday night.</p><p>Novavax did not immediately reply to MT Newswires' request for comment.</p><p>Novavax Chief Executive John Jacobs described the approval as a \"significant milestone\" in a statement cited by Reuters.</p><p>Shares of the US biotech firm were up more than 16% in recent premarket activity Monday.</p><p>Price: 7.86, Change: +1.13, Percent Change: +16.79</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Says COVID Vaccine Approved by US FDA in Restricted Cases; Shares Rise Pre-Bell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Says COVID Vaccine Approved by US FDA in Restricted Cases; Shares Rise Pre-Bell\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-19 17:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Novavax's (NVAX) COVID-19 vaccine has been approved for use by the US Food and Drug Administration but limited to only those over 65 years old and to those over 12 years old with underlying medical conditions, news outlets reported Saturday, citing company officials.</p><p>Reuters cited Novavax's Chief Corporate Affairs and Advocacy Officer Silvia Taylor as saying the approval for the drug, sold under the name Nuvaxovid, came late Friday night.</p><p>Novavax did not immediately reply to MT Newswires' request for comment.</p><p>Novavax Chief Executive John Jacobs described the approval as a \"significant milestone\" in a statement cited by Reuters.</p><p>Shares of the US biotech firm were up more than 16% in recent premarket activity Monday.</p><p>Price: 7.86, Change: +1.13, Percent Change: +16.79</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2536077235","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2536077235","pubTimestamp":1747648465,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Novavax's  COVID-19 vaccine has been approved for use by the US Food and Drug Administration but limited to only those over 65 years old and to those over 12 years old with underlying medical conditions, news outlets reported Saturday, citing company officials.Reuters cited Novavax's Chief Corporate Affairs and Advocacy Officer Silvia Taylor as saying the approval for the drug, sold under the name Nuvaxovid, came late Friday night.Novavax did not immediately reply to MT Newswires' request for comment.Novavax Chief Executive John Jacobs described the approval as a \"significant milestone\" in a statement cited by Reuters.Shares of the US biotech firm were up more than 16% in recent premarket activity Monday.Price: 7.86, Change: +1.13, Percent Change: +16.79","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BK4568":"美国抗疫概念","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4547":"WSB热门概念","BK4139":"生物科技"},"translate_title":"Novavax表示，美国FDA在有限情况下批准了COVID疫苗；盘前股价上涨","themeId":"3b1aaefae65b2972012958497a8f5cd2","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":1},"content_text":"Novavax's (NVAX) COVID-19 vaccine has been approved for use by the US Food and Drug Administration but limited to only those over 65 years old and to those over 12 years old with underlying medical conditions, news outlets reported Saturday, citing company officials.Reuters cited Novavax's Chief Corporate Affairs and Advocacy Officer Silvia Taylor as saying the approval for the drug, sold under the name Nuvaxovid, came late Friday night.Novavax did not immediately reply to MT Newswires' request for comment.Novavax Chief Executive John Jacobs described the approval as a \"significant milestone\" in a statement cited by Reuters.Shares of the US biotech firm were up more than 16% in recent premarket activity Monday.Price: 7.86, Change: +1.13, Percent Change: +16.79","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}